Position in ARGX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$860,234
-$197,681 QoQ
Shares Held
1,178
-6.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Caprock Group, LLC holds $22,978,162 across 21 Biotechnology names. ARGX ranks #5 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,007 | $13,399,325 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,768 | $2,138,667 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
7,880 | $1,489,714 | |
| 4 | TECH |
BIO-TECHNE Corp
|
19,976 | $1,043,945 | |
| 5 | ARGX |
Argenx SE
This page
|
1,178 | $860,234 | |
| 6 | AUPH |
Aurinia Pharmaceuticals Inc.
|
31,592 | $468,193 | |
| 7 | MRNA |
Moderna, Inc.
|
8,946 | $454,456 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,190 | $393,735 |
All Filings in ARGX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $860,234 | 1,178 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,057,915 | 1,258 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $556,857 | 755 | Shares | Sole | 2025-11-06 | |
| 2025-03-31 | $374,650 | 633 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $303,810 | 494 | Shares | Sole | 2025-01-23 | |
| No filing history on record for this holder in this stock. | ||||||